IGC Pharma (IGC) Profit After Tax (QoQ) (2010 - 2025)
IGC Pharma (IGC) Profit After Tax (QoQ) (2010 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
IGC Pharma |
27.49 Mn |
27.22 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
-13.88% |
| Jun 30, 2025 |
-33.47% |
| Mar 31, 2025 |
34.50% |
| Dec 31, 2024 |
-6.52% |
| Sep 30, 2024 |
27.80% |
| Jun 30, 2024 |
17.57% |
| Mar 31, 2024 |
48.38% |
| Dec 31, 2023 |
-128.03% |
| Sep 30, 2023 |
-18.12% |
| Jun 30, 2023 |
48.51% |
| Mar 31, 2023 |
-79.19% |
| Dec 31, 2022 |
7.90% |
| Sep 30, 2022 |
12.32% |
| Jun 30, 2022 |
57.17% |
| Mar 31, 2022 |
-173.12% |
| Dec 31, 2021 |
45.19% |
| Sep 30, 2021 |
-142.95% |
| Jun 30, 2021 |
39.37% |
| Mar 31, 2021 |
-26.95% |
| Dec 31, 2020 |
-40.19% |
